Title: Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.
2093152-79-3 | N-(Azido-PEG4)-N-bis(PEG4-t-butyl ester) | AA019E7R | MFCD30723292
2100306-59-8 | Meo2c-ch2-peg4-ch2co2tbu | AA019EBK | MFCD30828686
2183473-29-0 | BDP 581/591 maleimide | AA019EG7 | MFCD31580103
24583-84-4 | (E)-Methyl 3-(3-chlorophenyl)acrylate | AA019EJ8 | MFCD02149457
915030-12-5 | 3-[5-(Trifluoromethyl)pyridin-3-yl]propanoic acid | AA019EM4 | MFCD18259979
66223-53-8 | 2-Propenal, 3-(2-bromophenyl)- | AA019EPN | MFCD08448692
6959-84-8 | 4,6-dichloro-N-methylpyrimidin-5-amine | AA019ESW | MFCD20663093
20076-54-4 | 5,6-Dichloro-2-(methylthio)-1H-benzo[d]imidazole | AA019EW1 | MFCD00662340
502764-53-6 | thieno[3,2-b]thieno[2,2-d]thiophenedicarboxylicacid | AA019EYS | MFCD23103810
522-51-0 | Dequalinium Chloride | AA019FSP | MFCD00063502